Laura Sepp-Lorenzino
Director/Board Member at TAYSHA GENE THERAPIES, INC.
Net worth: 872 474 $ as of 30/01/2025
Profile
Dr. Laura Sepp-Lorenzino is an Independent Director at Taysha Gene Therapies, Inc. and a Chief Scientific Officer & Executive VP at Intellia Therapeutics, Inc. She is on the Board of Directors at Taysha Gene Therapies, Inc. Dr. Sepp-Lorenzino was previously employed as a VP, Head-Nucleic Acid Therapies & Research by Vertex Pharmaceuticals, Inc., a Vice President by Alnylam Pharmaceuticals, Inc., and an Executive Director & Head-RNA Therapeutics by Merck & Co., Inc. She received her undergraduate degree from Universidad de Buenos Aires, a graduate degree from New York University and a doctorate degree from New York University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
02/01/2025 | 77,388 ( 0.08% ) | 798 644 $ | 30/01/2025 | |
28/05/2024 | 49,220 ( 0.02% ) | 73 830 $ | 30/01/2025 |
Latest news about Laura Sepp-Lorenzino
Laura Sepp-Lorenzino active positions
Companies | Position | Start |
---|---|---|
TAYSHA GENE THERAPIES, INC. | Director/Board Member | 22/11/2020 |
Oligonucleotide Therapeutics Society, Inc.
![]() Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Director/Board Member | - |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | - |
Former positions of Laura Sepp-Lorenzino
Companies | Position | End |
---|---|---|
INTELLIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 12/01/2025 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 30/04/2019 |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/08/2017 |
MERCK & CO., INC. | Director/Board Member | 28/02/2014 |
Training of Laura Sepp-Lorenzino
New York University | Doctorate Degree |
Universidad de Buenos Aires | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
INTELLIA THERAPEUTICS, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
TAYSHA GENE THERAPIES, INC. | Health Technology |
Private companies | 2 |
---|---|
Oligonucleotide Therapeutics Society, Inc.
![]() Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
- Stock Market
- Insiders
- Laura Sepp-Lorenzino